Alnylam Pharmaceuticals | Należności Handlowe



Trade Debtors Zmiana Data
Acadia Pharmaceuticals USD 119.69M 5.97M 2025-06
Agios Pharmaceuticals USD 4.99M 1.64M 2025-06
Alnylam Pharmaceuticals USD 567.11M 149.08M 2025-06
Amgen USD 8.7B 569M 2025-06
Arrowhead Research USD 9.7M 7.33M 2025-06
BioMarin Pharmaceutical USD 855.85M 116.68M 2025-06
Incyte USD 842.89M 19.76M 2025-06
Ionis Pharmaceuticals USD 52.58M 12.87M 2025-06
Moderna USD 457M 151M 2025-06
Neurocrine Biosciences USD 595.7M 79.7M 2025-06
Novartis USD 9.18B 1.62B 2025-06
PTC Therapeutics USD 196.13M 14.36M 2025-06
Regeneron Pharmaceuticals USD 5.61B 49M 2025-06
Sanofi 8.21B 2.42B 2025-06
Sarepta Therapeutics USD 609.6M 114.93M 2025-06
Takeda JPY 679.53B 45.72B 2025-06
Tectonic Therapeutic USD 0 270K 2023-12
Ultragenyx Pharmaceutical USD 124.46M 25.62M 2025-06
Vertex Pharmaceuticals USD 1.89B 88.4M 2025-06
Xencor USD 47.55M 9.77M 2025-06


Alnylam Pharmaceuticals Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Sep 2025.